Press release
In-Situ Hybridization Market to Grow at 11.9% CAGR, Driven by Cancer Diagnostics and Key Players Like Abbott, Roche, and Thermo Fisher
In-Situ Hybridization Market
The In-Situ Hybridization (ISH) Market focuses on techniques using labeled DNA, RNA, or modified nucleic acid probes to localize specific nucleic acid sequences in tissue samples, cells, or circulating tumor cells (CTCs). Unlike immunohistochemistry, which targets proteins, ISH is critical for diagnosing cancer, genetic disorders, and infectious diseases, and is used in hospitals, diagnostic laboratories, academic institutes, pharmaceutical companies, and contract research organizations (CROs).
📌 Access valuable insights with our sample report - (Please enter your Corporate Email ID to get priority access):
https://www.datamintelligence.com/download-sample/in-situ-hybridization-market?sindhuri
☛ In-Situ Hybridization (ISH) Market Forces Driving Future Growth
The ISH market is driven by the rising incidence of cancer, linked to smoking, poor diet, and lifestyle factors, with approximately 10 million cancer deaths globally in 2020, per WHO. ISH's role in diagnosing cancer subtypes, chromosomal abnormalities, and genetic diseases fuels demand. Advancements like fluorescence in situ hybridization (FISH) and new product launches, such as Vizgen's multiplexed error-resilient FISH dataset in May 2021, enhance diagnostic precision and market growth.
Challenges include a lack of trained personnel with molecular expertise, particularly in developing countries, and resistance to transitioning from manual to automated ISH processes. These factors limit widespread adoption, especially in resource-constrained settings.
Opportunities lie in expanding applications in cancer diagnostics, infectious disease detection, and neuroscience, particularly in North America, where high cancer prevalence and R&D investments drive growth. The Asia-Pacific region's rising healthcare infrastructure and genetic research also offer significant potential.
☛ In-Situ Hybridization (ISH) Industry News
Product Launches: In May 2021, Vizgen launched a public spatial genomics dataset for multiplexed error-resilient FISH, mapping 483 gene transcripts in mouse brain receptors. In March 2020, Creative Bioarray introduced an improved FISH probe for detecting 2019 novel coronavirus in infected cells.
Partnerships: In April 2021, Applied Spectral Imaging and KromaTiD partnered to distribute KromaTiD's Pinpoint FISH probes globally. In May 2020, Leica Biosystems and Bio-Techne launched the CE-IVD RNAscope ISH Detection Kit for automation on the BOND-III platform in Europe.
Market Expansion: Growing product launches and collaborations in North America strengthen the region's dominance in the ISH market.
☛ In-Situ Hybridization (ISH) Market: Industry Giants and Emerging Leaders
✦ Abbott Laboratories
✦ F. Hoffmann-La Roche AG
✦ Becton, Dickinson and Company
✦ Agilent Technologies, Inc.
✦ Thermo Fisher Scientific
✦ Bio-Rad Laboratories, Inc.
✦ Bio-Techne Corporation
✦ Creative Bioarray
✦ Biocat GmbH
✦ Zytovision
Research Methodology
Our research methodology integrates qualitative and quantitative approaches to deliver reliable market intelligence. We conduct thorough secondary research using trusted industry publications, proprietary databases, and credible market sources, complemented by primary research involving structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
📌 Speak to Our Senior Analyst and Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/in-situ-hybridization-market
☛ Segments Covered in the In-Situ Hybridization (ISH) Market
By Product
Consumables (kits, reagents, probes, accessories) dominate due to recurring use in ISH workflows. Instruments and Software support automated and precise diagnostics.
By Technology
Fluorescence In Situ Hybridization (FISH) holds the largest share due to its use in cancer diagnostics, gene mapping, and chromosomal abnormality detection. Subtypes include DNA FISH, RNA FISH, PNA FISH, alongside Chromogenic In Situ Hybridization (CISH).
By Application
Cancer Diagnostics leads due to high cancer prevalence, followed by Cytology, Infectious Disease Diagnostics, Neuroscience, and Immunology, driven by ISH's precision in detecting genetic markers.
By End User
Hospitals & Diagnostic Laboratories dominate due to widespread diagnostic services. Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and CROs contribute through research and development.
☛ This Report Covers
✔ Go-to-market Strategy.
✔ Neutral perspective on market performance.
✔ Development trends, competitive landscape analysis, supply-side analysis, demand-side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analyses.
✔ Customized regional/country reports as per request and country-level analysis.
✔ Potential & niche segments and regions exhibiting promising growth.
✔ Top-down and bottom-up approach for regional analysis.
📌 Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=in-situ-hybridization-market
☛ Regional Analysis for In-Situ Hybridization (ISH) Market
⇥ North America (U.S., Canada, Mexico) - Dominates due to high cancer rates (1.9 million new cases in 2022, per American Cancer Society), frequent product launches, and robust R&D by key players.
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands, Rest of Europe) - Growing due to advancements in automated ISH platforms and research collaborations.
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia, Rest of Asia Pacific) - Fastest-growing region, driven by rising healthcare investments and genetic research.
⇥ South America (Colombia, Brazil, Argentina, Rest of South America) - Emerging market with increasing diagnostic capabilities.
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa) - Steady growth supported by expanding healthcare infrastructure.
📌 Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription
☛ Power Your Decisions with Real-Time Insights
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We leverage our top trademark trends, insights, and developments to deliver swift and astute solutions to clients. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-Situ Hybridization Market to Grow at 11.9% CAGR, Driven by Cancer Diagnostics and Key Players Like Abbott, Roche, and Thermo Fisher here
News-ID: 4174078 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
Bioprocess Validation Market to Grow at 11.2% CAGR, Driven by Pharma Safety Stan …
According to DataM Intelligence,the Bioprocess Validation Market was valued at US$ 224,687.30 million in 2021 and is expected to grow at a CAGR of 11.20% from 2024 to 2031.
The Bioprocess Validation Market involves processes to ensure consistent production of biopharmaceuticals and biological products meeting predefined quality and safety standards. It includes testing for contaminants like mycoplasma, bacteria, and endotoxins, and evaluating active pharmaceutical ingredients (APIs) during development and manufacturing. The…
US Telecom Enterprise Services Market Latest NEWS 2025 | American Tower Reports …
Global Telecom Enterprise Services Market reached US$ 1.8 billion in 2022 and is expected to reach US$ 2.9 billion by 2031, growing with a CAGR of 6.1% during the forecast period 2024-2031.
The Telecom Enterprise Services Market takes center stage in DataM Intelligence's latest in-depth analysis, where expert researchers apply advanced analytics and strategic foresight to deliver unmatched market intelligence. This comprehensive report offers a detailed examination of the competitive landscape,…
US Discrete Semiconductors Market Latest NEWS 2025 | U.S. Initiates Semiconducto …
The Global Discrete Semiconductors Market reached US$ 33.7 billion in 2022 and is expected to reach US$ 97.5 billion by 2031, growing with a CAGR of 14.2% during the forecast period 2024-2031.
The Discrete Semiconductors Market takes center stage in DataM Intelligence's latest in-depth analysis, where expert researchers apply advanced analytics and strategic foresight to deliver unmatched market intelligence. This comprehensive report offers a detailed examination of the competitive landscape, highlighting…
Protein Detection and Quantification Market Fueled by 9.6% CAGR and Key Players …
According to DataM Intelligence,the Protein Detection Quantification Market was valued at US$ 2.25 billion in 2022 and is expected to grow at a CAGR of 9.60% from 2024 to 2031.
The Protein Detection Quantification Market focuses on technologies and products used to detect and measure protein levels, crucial for understanding post-translational modifications and peptide functions in medicine and cell biology. Applications include drug discovery, clinical diagnostics, and protein characterization, serving academic…
More Releases for ISH
How big is In-Situ Hybridization (ISH) Market?
A new Report by DataM Intelligence, titled "In-Situ Hybridization (ISH) Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the In-Situ Hybridization (ISH) market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The In-Situ Hybridization…
In-situ Hybridization (ISH) Market Analysis and Future Prospects for 2030
The world of the in-situ hybridization (ish) market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing…
In Situ Hybridization (ISH) Market Research Report 2015-2025
About the Global In Situ Hybridization (ISH) Market Research Report 2015-2025:
Global In Situ Hybridization (ISH) Market Research Report 2015-2025 is divided into various key segments like device type, material, applications, and end users. The report is thoroughly analyzed and studied by the researchers to offer deep insights on each of these segments with statistics. This information is beneficial for the manufacturers in the industry to plan their policies and strategies…
In Situ Hybridization (ISH) Market to Record an Exponential CAGR by 2025
Researchmoz added Most up-to-date research on "In Situ Hybridization (ISH) Market to Record an Exponential CAGR by 2025" to its huge collection of research reports.
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small…
Ish Spencer Becomes Managing Director and Partner at US Capital Partners
Private investment bank promotes senior executive to partnership level, following another year of strong growth at the firm.
San Francisco, CA, USA, March 16, 2016 -- US Capital Partners Inc. is pleased to announce the recent appointment of Ish Spencer as Managing Director and Partner at the firm. Headquartered in San Francisco, US Capital Partners is a private investment bank that makes direct debt investments between $500,000 and $100 million, participates…
Showcase of World’s first self-powered CO2 Sensor at ISH 2011
EnOcean Alliance member Gas Sending Solutions (GSS) announces first commercially available wireless CO2 sensor for sustainable buildings
Cumbernauld, Scotland, 2 March 2011 — Gas Sending Solutions (GSS) will showcase the world’s lowest power CO2 gas sensor enabled by revolutionary EnOcean self-powered wireless technology at ISH 2011 – the leading international trade fair for innovative bathroom design, energy efficient heating and air-conditioning technology and renewable energies – taking place in Frankfurt, 15-19…
